Hospital Readmissions After Continuous-Flow Left Ventricular Assist Device Implantation: Incidence, Causes, and Cost Analysis

摘要: Background We investigated the incidence and causes of unplanned hospital readmissions after continuous-flow (CF) left ventricular assist device (LVAD) implantation. also analyzed impact on post–CF-LVAD survival costs associated with each cause readmission. Methods retrospectively reviewed 126 patients who underwent implantation a CF-LVAD from January 2007 to December 2013. The timing readmissions, length stay, total support were evaluated. Patients followed up while receiving support, until transplantation, or death. Direct readmission analyzed. Results In all, 103 for bridge transplantation 19 destination therapy; 68 readmitted 156 times (2.2 times/patient) as end follow-up. median follow-up period was 11 months. While spent 93% their time out hospital. included gastrointestinal bleeding (19%), driveline infection (13%), stroke (8%). first 35 days. Thirty (44%) within 30 days discharge. direct cost single $7,546. Device malfunction arrhythmias most costly There no significant difference in long-term between those not readmitted. Conclusions Gastrointestinal CF-LVAD–related infections leading implantation, did have negative survival. New approaches minimize these adverse events will continue improve efficacy decrease therapy.